• Alexa Diabetes Challenge

    Sponsored by Merck & Co., Inc., Kenilworth, New Jersey, U.S.A.

    The Challenge calls on innovators to create Alexa voice-enabled solutions to improve the lives of those with type 2 diabetes.


    Learn more about the Challenge
  • Call for Submissions
    April 10, 2017
  • Current StageSubmission Deadline
    May 22, 2017
  • Finalists Announced
    July 2017
  • Virtual Accelerator
    July - September 2017
  • Demo Day
    September 25, 2017
  • Winner Announced
    October 2017
Detailed Schedule

Introducing a new voice in diabetes management

An estimated 27.5 million people live with type 2 diabetes in the United States. Thanks to greater awareness and better treatments, many who have been diagnosed with the disease are living longer, healthier lives. But diabetes requires changes and considerations that permeate throughout every aspect of life. It’s easy to feel overwhelmed and isolated on the path to self-management, especially for people who are newly diagnosed.

Amazon voice-enabled solutions have the potential to be a new partner for this journey. As voice technology transforms the way we live, could it shift from helping manage playlists to helping manage disease?

The Alexa Diabetes Challenge invites you to be among the first to explore how voice-enabled solutions and the ecosystem of supporting cloud technologies provided by Amazon Web Services can improve the experience of those newly diagnosed with type 2 diabetes.

More about the challenge




up to 5 finalists receive $25,000

1 grand prize winner receives $125,000


Each Finalist will also be awarded 10,000 AWS credits to help cover the Amazon Web Services usage costs. Credits may only be granted to companies.

Cash awards for this Challenge will be paid by electronic funds transfer. Winners are responsible for any applicable local, State, and Federal taxes and reporting that may be required under applicable tax laws.

More about Awards